Apalutamide-Induced Toxic Epidermal Necrolysis in a Caucasian Patient with Metastatic Castration-Sensitive Prostate Cancer: A Case Report and Review of the Literature

Apalutamide is a novel nonsteroidal androgen receptor inhibitor that has been shown to improve outcomes for patients with nonmetastatic castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer when combined with androgen deprivation therapy. Apalutamide-induced skin r...

Full description

Bibliographic Details
Main Authors: Calvin R. Flynn, Shun-Chieh Liu, Berbie Byrne, James Ralph, Gabriela Paz, Salman Anwar, Jemma Buchalter, Orla M. Fitzpatrick, Trevor Markham, Paul Donnellan
Format: Article
Language:English
Published: Karger Publishers 2023-08-01
Series:Case Reports in Oncology
Subjects:
Online Access:https://beta.karger.com/Article/FullText/532009